MedPath

ODEFSEY 200 MG/25 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

ODEFSEY 200 MG/25 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

1161112001

Prescription Type

Uso Hospitalario

Authorization Date

Jul 12, 2016

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1161112001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (3)

EMTRICITABINAActive
Quantity: 200 mg
Name: EMTRICITABINA
RILPIVIRINAActive
Quantity: 25 mg
Name: RILPIVIRINA
TENOFOVIR ALAFENAMIDAActive
Quantity: 25 mg
Name: TENOFOVIR ALAFENAMIDA

ATC CLASSIFICATION (3)

J05A
J05AR
J05AR19

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.